Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.
about
Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptorBreast cancer and social environment: getting by with a little help from our friendsRe-Use of Established Drugs for Anti-Metastatic IndicationsSympathetic nervous system regulation of the tumour microenvironmentβ-Adrenergic Receptor Signaling in Prostate CancerTargeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic ApproachDivergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytesGalphas-coupled receptor signaling actively down-regulates alpha4beta1-integrin affinity: a possible mechanism for cell de-adhesion.Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration.Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47DThe sympathetic nervous system induces a metastatic switch in primary breast cancer.Tumor interactions with soluble factors and the nervous system.Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasisInvolvement of substance P and the NK-1 receptor in human pathology.The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.Impact of stress on cancer metastasisEffect of chronic restraint stress on human colorectal carcinoma growth in mice.The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survivalBeta-adrenergic signaling, a novel target for cancer therapy?Long-Term Use of Antihypertensive Agents and Risk of Breast Cancer: A Population-Based Case-Control Study.Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.Molecular pathways: beta-adrenergic signaling in cancerEfficiency of calcium phosphate composite nanoparticles in targeting Ehrlich carcinoma cells transplanted in mice.Beta-adrenergic blocking drugs in breast cancer: a perspective reviewThe significance of substance P in physiological and malignant haematopoiesisMechanisms of propranolol action in infantile hemangiomaβ-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.β-blockers: a novel class of antitumor agents.Nervous system regulation of the cancer genome.Neuroendocrine influences on cancer biology.Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinomaBeta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinomaNeurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: implications for intervention.Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid.β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPrognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer
P2860
Q24635201-7A3CD4C8-0FFB-4045-BE7C-21D7E90FED29Q26745963-3E6F20C3-0C28-4FCC-890C-E7E7008B725AQ26771704-89EF3666-53C7-4FF3-A27A-1EA3000E1FD5Q26795614-61236AFD-F697-40AA-991A-F1C9C2299950Q28084943-B711B219-A8D6-434D-8C8B-B3B8535AD8BDQ28085005-DADA6A89-80E3-4130-9541-927E2D5DFFFEQ30962488-36E339FD-5292-46E1-B1DB-2E3C3378D9A2Q33340853-AC5FE4DB-E88F-43B1-A57B-B22E39B5A19CQ33582909-9F102B9C-93AE-4C23-907B-54C71E110EC5Q33887570-E926AAA4-92D9-4105-BABB-8013DBF69A8CQ33933654-3851A3F3-4997-4725-8BC6-C4962A3C0E94Q34134468-A68DB2FE-AEB8-462A-A119-4B1565B90622Q34142510-589A2393-9722-495F-A00F-DF30742B53F4Q34285076-050A504E-8D3C-4998-BDBB-83A163D1D720Q34413850-41648D67-1904-440B-AF42-DBC42CDE530BQ34475975-5950C8EB-F75B-41E2-8AC3-78AE934862E7Q34569251-06ED5C66-CE5F-4A70-B2D5-C69CBF23B365Q34667999-D449EE0A-A7E7-4BAB-AFDA-AA4617F8AFC0Q35135129-287727DC-2F6E-4494-A0F1-F8654378345CQ35640094-F80F8450-302B-4023-89A9-7371D2B5127EQ35640106-5CA6C51E-3584-4B8D-8A0A-EFD3046BDE1FQ35756617-4279F7F4-E0EC-449C-8696-BDA0D7F85CA5Q35773945-6B209849-95BB-4523-AA7B-6F643BA44282Q35803280-3B0FEDAD-357E-4927-9E03-AA076205E564Q35914285-E6D32AF7-F7A7-476E-9EAC-0B064F6DF7BFQ35949297-5589BCE7-A71F-4F84-877B-9926D29ACF58Q36017182-2E3E0CC7-7441-417D-A9B1-F7D48D2889F4Q36085996-67AE7229-7510-4B01-B1AD-2404270B3415Q36213505-D5326039-05DB-4259-9F8C-F36A3B61C606Q36443830-B7B9507E-5F82-4627-853F-86D4A71168AEQ36692566-BB7D40F6-FB96-463D-AF34-A656F77BDE02Q36713229-DFC25FFE-4DE7-470A-A784-416B65292D22Q36916872-70F2101A-A4A2-496A-A759-F6A93A3D3514Q36953333-FEE51347-5B30-48D8-AB59-0461742CB9E6Q37004651-DBF8D9A2-9D84-4127-B76C-28DF348EECE8Q37087599-EB6503C0-99AF-43F3-A53E-156837E901C6Q37292726-8E801EBF-1033-483A-85E3-B131EDFF67EAQ37300549-C955970B-957D-4190-B891-9B8DEF03A939Q37404693-A5F49663-45D3-4103-A90F-F655792BCD03Q37448247-6644B9DE-3E01-44C1-B741-645947FE869E
P2860
Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Induction of a metastatogenic ...... hibition by established drugs.
@en
type
label
Induction of a metastatogenic ...... hibition by established drugs.
@en
prefLabel
Induction of a metastatogenic ...... hibition by established drugs.
@en
P2093
P2860
P356
P1476
Induction of a metastatogenic ...... hibition by established drugs.
@en
P2093
Antje Lindecke
Bernd Niggemann
Christian Kaltschmidt
Frank Entschladen
Kerstin Lang
Kurt S Zaenker
Theodore L Drell
P2860
P304
P356
10.1002/IJC.20410
P577
2004-11-01T00:00:00Z